嘌呤能ADP受体:从重磅血液药物到骨病重磅药物

{"title":"嘌呤能ADP受体:从重磅血液药物到骨病重磅药物","authors":"A. Gartland","doi":"10.1038/BONEKEY.2013.41","DOIUrl":null,"url":null,"abstract":"","PeriodicalId":13153,"journal":{"name":"Ibms Bonekey","volume":"24 1","pages":""},"PeriodicalIF":0.0000,"publicationDate":"2013-03-27","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"1","resultStr":"{\"title\":\"Purinergic ADP receptors: from block buster blood drugs to bone-disease busters\",\"authors\":\"A. Gartland\",\"doi\":\"10.1038/BONEKEY.2013.41\",\"DOIUrl\":null,\"url\":null,\"abstract\":\"\",\"PeriodicalId\":13153,\"journal\":{\"name\":\"Ibms Bonekey\",\"volume\":\"24 1\",\"pages\":\"\"},\"PeriodicalIF\":0.0000,\"publicationDate\":\"2013-03-27\",\"publicationTypes\":\"Journal Article\",\"fieldsOfStudy\":null,\"isOpenAccess\":false,\"openAccessPdf\":\"\",\"citationCount\":\"1\",\"resultStr\":null,\"platform\":\"Semanticscholar\",\"paperid\":null,\"PeriodicalName\":\"Ibms Bonekey\",\"FirstCategoryId\":\"1085\",\"ListUrlMain\":\"https://doi.org/10.1038/BONEKEY.2013.41\",\"RegionNum\":0,\"RegionCategory\":null,\"ArticlePicture\":[],\"TitleCN\":null,\"AbstractTextCN\":null,\"PMCID\":null,\"EPubDate\":\"\",\"PubModel\":\"\",\"JCR\":\"\",\"JCRName\":\"\",\"Score\":null,\"Total\":0}","platform":"Semanticscholar","paperid":null,"PeriodicalName":"Ibms Bonekey","FirstCategoryId":"1085","ListUrlMain":"https://doi.org/10.1038/BONEKEY.2013.41","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"","JCRName":"","Score":null,"Total":0}